Epstein Secrets

o what is off-limits." DHS Says Becton Medical Pump Has Cybersecurity Issues. EFTA00148988 Law360 (11/13, Subscription Publication, 8K) reports, "Becton Dickinson & Co.'s Alaris infusion pump has cybersecurity weaknesses that, if exploited, could force users, typically hospitals, to operate them manually," DHS announ

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

o what is off-limits." DHS Says Becton Medical Pump Has Cybersecurity Issues. EFTA00161628 Law360 (11/13, Subscription Publication, 8K) reports, "Becton Dickinson & Co.'s Alaris infusion pump has cybersecurity weaknesses that, if exploited, could force users, typically hospitals, to operate them manually," DHS announ

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

ese issues as to what is off-limits." DHS Says Becton Medical Pump Has Cybersecurity Issues. Law360 (11/13, Subscription Publication, 8K) reports, "Becton Dickinson & Co.'s Alaris infusion pump has cybersecurity weaknesses that, if exploited, could force users, typically hospitals, to operate them manually," DHS announ

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying